When a buyer pays 88% above where a stock was trading, one of two things is true: either the acquirers are reckless, or the market was badly wrong. In the case of The Baldwin Group, the buyers are Michael Dell’s family office, DFO Management, and a holding company called Sequence. Reckless is a hard argument to make.
The transaction implies a total enterprise value of approximately $7.7 billion, comprised of an equity purchase price of approximately $4.6 billion and approximately $3.1 billion of net debt assumed or refinanced in connection with the transaction. Shareholders will receive $32.50 per share, an approximately 88% premium to the unaffected June 17, 2026, closing price. With no financing conditions, the parties expect to complete the deal in the first quarter of 2027.
Why This Deal Happened Now
Baldwin competes with large publicly traded insurance brokers including Aon, Marsh & McLennan, Willis Towers Watson, Arthur J. Gallagher, and Brown & Brown, as well as significant private competitors such as AssuredPartners, Hub International, and USI. Those peers were being acquired and revalued throughout 2024 and 2025 at escalating EBITDA multiples. Baldwin, a mid-sized independent distributor with trailing 12-month revenue of roughly $1.74 billion, kept getting overlooked.
Baldwin said the $7.7 billion total enterprise value represents an implied multiple of approximately 20x its trailing 12-month adjusted EBITDA of approximately $396 million. For context, Aon’s acquisition of USI announced on August 31, 2026, has a multiple of about 14.5 times synergized trailing EBITDA, while EQT’s acquisition of McGill and Partners announced September 4, 2026, values the business at $2.0 billion. Baldwin is priced right at that upper range, a sharp rebuke to the public market’s prior assessment.
The Investment Thesis
The core argument here is straightforward: BWIN was a mispriced asset in a consolidating industry, and the buyers saw it first. In its second-quarter 2026 earnings report, Baldwin posted total revenue of $492.9 million, up 30% from the same period a year earlier, and adjusted diluted earnings per share of 48 cents, up 14% year over year. That growth profile did not show up in the public share price before June 17.
Sequence is described in the deal materials as a permanent holding company that acquires established enterprises in the service economy and then uses AI and its technology platform to modernize them. DFO is investing directly in the Baldwin deal and is also becoming an investor in Sequence. That dual structure suggests Dell sees Sequence itself as a vehicle worth owning, not just a co-investor on a single deal.
CEO Trevor Baldwin said the vision and strategy are not changing: “We remain committed to building the most diversified, vertically integrated insurance firm of the future.” What changes, he added, is the pace of investments in talent and technology. “Moving faster on AI sharpens what we deliver for clients.”
What Investors in Peer Stocks Should Watch
The more interesting question for investors who missed BWIN is where this leaves comparable public brokers. Four insurance brokerage mega-deals were announced in 2024 and 2025: Gallagher-AssuredPartners at about $13.45 billion, Aon-NFP at $13 billion, Brown & Brown-Accession at $9.825 billion, and Marsh-McGriff at $7.75 billion. Those four deals totaled a little over $44 billion and reshaped the industry.
Public brokers took a hit in late February 2026 amid AI disruption headlines, with Brown & Brown sliding about 8%. Still, analysts believe institutional demand and strategic acquisition needs will support midmarket valuations for at least the remainder of 2026. That analyst view looks more credible today than it did last week.
The Risks
Baldwin carries real debt. The buyers are absorbing that leverage. Whether the AI productivity gains Sequence is promising arrive fast enough to service it is the central question for the private company going forward.
The transaction was unanimously approved by Baldwin’s board and an independent special committee, and will remove the stock from Nasdaq once completed, subject to shareholder and regulatory approvals. Regulatory clearance in a still-consolidating brokerage sector is not guaranteed quickly.
Bottom Line
An 88% premium does not happen because a buyer likes the brand. It happens because the math worked at a valuation the public market refused to assign. TD Cowen called Sequence and DFO “ideal owners” of Baldwin, citing Sequence’s focus on advancing AI and tech capabilities and DFO’s long-duration capital as distinct advantages. The remaining publicly traded mid-tier insurance brokers are still priced at the old multiple. If another buyer is running the same spreadsheet Dell’s team ran on Baldwin, that may not last long.
Rising Star Stocks